Pyruvate dehydrogenase complex deficiency mimicking congenital cytomegalovirus infection on imaging

Jasmin Rahesh1, Rohan Anand1, Victor Mendiola1

  • 1School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas.

Proceedings (Baylor University. Medical Center)
|March 9, 2022
PubMed

Insights

Pyruvate dehydrogenase complex deficiency (PDCD) is a rare genetic disorder. Early diagnosis via genetic testing is crucial for dietary treatment and preventing brain damage.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Pyruvate dehydrogenase complex deficiency (PDCD) is a rare, often underdiagnosed metabolic disorder.
  • PDCD can manifest with severe clinical symptoms, detectable even before birth.

Observation:

  • A newborn presented with in utero brain abnormalities on ultrasound.
  • These abnormalities initially mimicked cytomegalovirus infection.

Findings:

  • Genetic testing confirmed the diagnosis of pyruvate dehydrogenase complex deficiency.
  • This highlights the importance of genetic analysis in diagnosing rare metabolic disorders.

Implications:

  • Early detection and diagnosis of PDCD are critical for patient survival.
  • Timely dietary intervention can prevent irreversible neurological and structural brain damage.